VDR and hypercalcemia disease: Probably,residual VDR agonistic effects in 2 and 3 arise because the A-ring is accessible for interactions with 1-αhydroxylase; for similar reasons, 2 and 3 may also exhibit hypercalcemia if administered in animals.